 | • レポートコード：MRC2-11QY06841 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はグリア細胞株由来神経栄養因子のグローバル市場について調査・分析したレポートです。種類別（GSK-812、LAUR-301、TW-002、AMT-090、その他）市場規模、用途別（筋萎縮性側索硬化症、脳虚血、パーキンソン病、網膜変性、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別グリア細胞株由来神経栄養因子の競争状況、市場シェア ・世界のグリア細胞株由来神経栄養因子市場：種類別市場規模 2015年-2020年（GSK-812、LAUR-301、TW-002、AMT-090、その他） ・世界のグリア細胞株由来神経栄養因子市場：種類別市場規模予測 2021年-2026年（GSK-812、LAUR-301、TW-002、AMT-090、その他） ・世界のグリア細胞株由来神経栄養因子市場：用途別市場規模 2015年-2020年（筋萎縮性側索硬化症、脳虚血、パーキンソン病、網膜変性、その他） ・世界のグリア細胞株由来神経栄養因子市場：用途別市場規模予測 2021年-2026年（筋萎縮性側索硬化症、脳虚血、パーキンソン病、網膜変性、その他） ・北米のグリア細胞株由来神経栄養因子市場分析：米国、カナダ ・ヨーロッパのグリア細胞株由来神経栄養因子市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのグリア細胞株由来神経栄養因子市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のグリア細胞株由来神経栄養因子市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのグリア細胞株由来神経栄養因子市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：GlaxoSmithKline Plc、Treeway BV、UniQure NV ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Glial Cell Line Derived Neurotrophic Factor Market
The global Glial Cell Line Derived Neurotrophic Factor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Glial Cell Line Derived Neurotrophic Factor Scope and Market Size
Glial Cell Line Derived Neurotrophic Factor market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Glial Cell Line Derived Neurotrophic Factor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Glial Cell Line Derived Neurotrophic Factor market is segmented into
GSK-812
LAUR-301
TW-002
AMT-090
Others
Segment by Application, the Glial Cell Line Derived Neurotrophic Factor market is segmented into
Amyotrophic Lateral Sclerosis
Brain Ischemia
Parkinson’s Disease
Retinal Degeneration
Others
Regional and Country-level Analysis
The Glial Cell Line Derived Neurotrophic Factor market is analysed and market size information is provided by regions (countries).
The key regions covered in the Glial Cell Line Derived Neurotrophic Factor market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Glial Cell Line Derived Neurotrophic Factor Market Share Analysis
Glial Cell Line Derived Neurotrophic Factor market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Glial Cell Line Derived Neurotrophic Factor business, the date to enter into the Glial Cell Line Derived Neurotrophic Factor market, Glial Cell Line Derived Neurotrophic Factor product introduction, recent developments, etc.
The major vendors covered:
GlaxoSmithKline Plc
Treeway BV
UniQure NV
…
1 Study Coverage
1.1 Glial Cell Line Derived Neurotrophic Factor Product Introduction
1.2 Market Segments
1.3 Key Glial Cell Line Derived Neurotrophic Factor Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Glial Cell Line Derived Neurotrophic Factor Market Size Growth Rate by Type
1.4.2 GSK-812
1.4.3 LAUR-301
1.4.4 TW-002
1.4.5 AMT-090
1.4.6 Others
1.5 Market by Application
1.5.1 Global Glial Cell Line Derived Neurotrophic Factor Market Size Growth Rate by Application
1.5.2 Amyotrophic Lateral Sclerosis
1.5.3 Brain Ischemia
1.5.4 Parkinson’s Disease
1.5.5 Retinal Degeneration
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Glial Cell Line Derived Neurotrophic Factor Market Size, Estimates and Forecasts
2.1.1 Global Glial Cell Line Derived Neurotrophic Factor Revenue 2015-2026
2.1.2 Global Glial Cell Line Derived Neurotrophic Factor Sales 2015-2026
2.2 Global Glial Cell Line Derived Neurotrophic Factor, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Glial Cell Line Derived Neurotrophic Factor Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Glial Cell Line Derived Neurotrophic Factor Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Glial Cell Line Derived Neurotrophic Factor Competitor Landscape by Players
3.1 Glial Cell Line Derived Neurotrophic Factor Sales by Manufacturers
3.1.1 Glial Cell Line Derived Neurotrophic Factor Sales by Manufacturers (2015-2020)
3.1.2 Glial Cell Line Derived Neurotrophic Factor Sales Market Share by Manufacturers (2015-2020)
3.2 Glial Cell Line Derived Neurotrophic Factor Revenue by Manufacturers
3.2.1 Glial Cell Line Derived Neurotrophic Factor Revenue by Manufacturers (2015-2020)
3.2.2 Glial Cell Line Derived Neurotrophic Factor Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Glial Cell Line Derived Neurotrophic Factor Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Glial Cell Line Derived Neurotrophic Factor Revenue in 2019
3.2.5 Global Glial Cell Line Derived Neurotrophic Factor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Glial Cell Line Derived Neurotrophic Factor Price by Manufacturers
3.4 Glial Cell Line Derived Neurotrophic Factor Manufacturing Base Distribution, Product Types
3.4.1 Glial Cell Line Derived Neurotrophic Factor Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Glial Cell Line Derived Neurotrophic Factor Product Type
3.4.3 Date of International Manufacturers Enter into Glial Cell Line Derived Neurotrophic Factor Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Glial Cell Line Derived Neurotrophic Factor Market Size by Type (2015-2020)
4.1.1 Global Glial Cell Line Derived Neurotrophic Factor Sales by Type (2015-2020)
4.1.2 Global Glial Cell Line Derived Neurotrophic Factor Revenue by Type (2015-2020)
4.1.3 Glial Cell Line Derived Neurotrophic Factor Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Glial Cell Line Derived Neurotrophic Factor Market Size Forecast by Type (2021-2026)
4.2.1 Global Glial Cell Line Derived Neurotrophic Factor Sales Forecast by Type (2021-2026)
4.2.2 Global Glial Cell Line Derived Neurotrophic Factor Revenue Forecast by Type (2021-2026)
4.2.3 Glial Cell Line Derived Neurotrophic Factor Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Glial Cell Line Derived Neurotrophic Factor Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Glial Cell Line Derived Neurotrophic Factor Market Size by Application (2015-2020)
5.1.1 Global Glial Cell Line Derived Neurotrophic Factor Sales by Application (2015-2020)
5.1.2 Global Glial Cell Line Derived Neurotrophic Factor Revenue by Application (2015-2020)
5.1.3 Glial Cell Line Derived Neurotrophic Factor Price by Application (2015-2020)
5.2 Glial Cell Line Derived Neurotrophic Factor Market Size Forecast by Application (2021-2026)
5.2.1 Global Glial Cell Line Derived Neurotrophic Factor Sales Forecast by Application (2021-2026)
5.2.2 Global Glial Cell Line Derived Neurotrophic Factor Revenue Forecast by Application (2021-2026)
5.2.3 Global Glial Cell Line Derived Neurotrophic Factor Price Forecast by Application (2021-2026)
6 North America
6.1 North America Glial Cell Line Derived Neurotrophic Factor by Country
6.1.1 North America Glial Cell Line Derived Neurotrophic Factor Sales by Country
6.1.2 North America Glial Cell Line Derived Neurotrophic Factor Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Glial Cell Line Derived Neurotrophic Factor Market Facts & Figures by Type
6.3 North America Glial Cell Line Derived Neurotrophic Factor Market Facts & Figures by Application
7 Europe
7.1 Europe Glial Cell Line Derived Neurotrophic Factor by Country
7.1.1 Europe Glial Cell Line Derived Neurotrophic Factor Sales by Country
7.1.2 Europe Glial Cell Line Derived Neurotrophic Factor Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Glial Cell Line Derived Neurotrophic Factor Market Facts & Figures by Type
7.3 Europe Glial Cell Line Derived Neurotrophic Factor Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Glial Cell Line Derived Neurotrophic Factor by Region
8.1.1 Asia Pacific Glial Cell Line Derived Neurotrophic Factor Sales by Region
8.1.2 Asia Pacific Glial Cell Line Derived Neurotrophic Factor Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Glial Cell Line Derived Neurotrophic Factor Market Facts & Figures by Type
8.3 Asia Pacific Glial Cell Line Derived Neurotrophic Factor Market Facts & Figures by Application
9 Latin America
9.1 Latin America Glial Cell Line Derived Neurotrophic Factor by Country
9.1.1 Latin America Glial Cell Line Derived Neurotrophic Factor Sales by Country
9.1.2 Latin America Glial Cell Line Derived Neurotrophic Factor Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Glial Cell Line Derived Neurotrophic Factor Market Facts & Figures by Type
9.3 Central & South America Glial Cell Line Derived Neurotrophic Factor Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Glial Cell Line Derived Neurotrophic Factor by Country
10.1.1 Middle East and Africa Glial Cell Line Derived Neurotrophic Factor Sales by Country
10.1.2 Middle East and Africa Glial Cell Line Derived Neurotrophic Factor Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Glial Cell Line Derived Neurotrophic Factor Market Facts & Figures by Type
10.3 Middle East and Africa Glial Cell Line Derived Neurotrophic Factor Market Facts & Figures by Application
11 Company Profiles
11.1 GlaxoSmithKline Plc
11.1.1 GlaxoSmithKline Plc Corporation Information
11.1.2 GlaxoSmithKline Plc Description and Business Overview
11.1.3 GlaxoSmithKline Plc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GlaxoSmithKline Plc Glial Cell Line Derived Neurotrophic Factor Products Offered
11.1.5 GlaxoSmithKline Plc Related Developments
11.2 Treeway BV
11.2.1 Treeway BV Corporation Information
11.2.2 Treeway BV Description and Business Overview
11.2.3 Treeway BV Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Treeway BV Glial Cell Line Derived Neurotrophic Factor Products Offered
11.2.5 Treeway BV Related Developments
11.3 UniQure NV
11.3.1 UniQure NV Corporation Information
11.3.2 UniQure NV Description and Business Overview
11.3.3 UniQure NV Sales, Revenue and Gross Margin (2015-2020)
11.3.4 UniQure NV Glial Cell Line Derived Neurotrophic Factor Products Offered
11.3.5 UniQure NV Related Developments
11.1 GlaxoSmithKline Plc
11.1.1 GlaxoSmithKline Plc Corporation Information
11.1.2 GlaxoSmithKline Plc Description and Business Overview
11.1.3 GlaxoSmithKline Plc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GlaxoSmithKline Plc Glial Cell Line Derived Neurotrophic Factor Products Offered
11.1.5 GlaxoSmithKline Plc Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Glial Cell Line Derived Neurotrophic Factor Market Estimates and Projections by Region
12.1.1 Global Glial Cell Line Derived Neurotrophic Factor Sales Forecast by Regions 2021-2026
12.1.2 Global Glial Cell Line Derived Neurotrophic Factor Revenue Forecast by Regions 2021-2026
12.2 North America Glial Cell Line Derived Neurotrophic Factor Market Size Forecast (2021-2026)
12.2.1 North America: Glial Cell Line Derived Neurotrophic Factor Sales Forecast (2021-2026)
12.2.2 North America: Glial Cell Line Derived Neurotrophic Factor Revenue Forecast (2021-2026)
12.2.3 North America: Glial Cell Line Derived Neurotrophic Factor Market Size Forecast by Country (2021-2026)
12.3 Europe Glial Cell Line Derived Neurotrophic Factor Market Size Forecast (2021-2026)
12.3.1 Europe: Glial Cell Line Derived Neurotrophic Factor Sales Forecast (2021-2026)
12.3.2 Europe: Glial Cell Line Derived Neurotrophic Factor Revenue Forecast (2021-2026)
12.3.3 Europe: Glial Cell Line Derived Neurotrophic Factor Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Glial Cell Line Derived Neurotrophic Factor Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Glial Cell Line Derived Neurotrophic Factor Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Glial Cell Line Derived Neurotrophic Factor Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Glial Cell Line Derived Neurotrophic Factor Market Size Forecast by Region (2021-2026)
12.5 Latin America Glial Cell Line Derived Neurotrophic Factor Market Size Forecast (2021-2026)
12.5.1 Latin America: Glial Cell Line Derived Neurotrophic Factor Sales Forecast (2021-2026)
12.5.2 Latin America: Glial Cell Line Derived Neurotrophic Factor Revenue Forecast (2021-2026)
12.5.3 Latin America: Glial Cell Line Derived Neurotrophic Factor Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Glial Cell Line Derived Neurotrophic Factor Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Glial Cell Line Derived Neurotrophic Factor Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Glial Cell Line Derived Neurotrophic Factor Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Glial Cell Line Derived Neurotrophic Factor Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Glial Cell Line Derived Neurotrophic Factor Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Glial Cell Line Derived Neurotrophic Factor Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Glial Cell Line Derived Neurotrophic Factor Market Segments
Table 2. Ranking of Global Top Glial Cell Line Derived Neurotrophic Factor Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Glial Cell Line Derived Neurotrophic Factor Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of GSK-812
Table 5. Major Manufacturers of LAUR-301
Table 6. Major Manufacturers of TW-002
Table 7. Major Manufacturers of AMT-090
Table 8. Major Manufacturers of Others
Table 9. Global Glial Cell Line Derived Neurotrophic Factor Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Glial Cell Line Derived Neurotrophic Factor Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Glial Cell Line Derived Neurotrophic Factor Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Glial Cell Line Derived Neurotrophic Factor Sales Market Share by Regions (2015-2020)
Table 13. Global Glial Cell Line Derived Neurotrophic Factor Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Glial Cell Line Derived Neurotrophic Factor Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Glial Cell Line Derived Neurotrophic Factor Sales Share by Manufacturers (2015-2020)
Table 16. Global Glial Cell Line Derived Neurotrophic Factor Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Glial Cell Line Derived Neurotrophic Factor by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glial Cell Line Derived Neurotrophic Factor as of 2019)
Table 18. Glial Cell Line Derived Neurotrophic Factor Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Glial Cell Line Derived Neurotrophic Factor Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Glial Cell Line Derived Neurotrophic Factor Price (2015-2020) (USD/Pcs)
Table 21. Glial Cell Line Derived Neurotrophic Factor Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Glial Cell Line Derived Neurotrophic Factor Product Type
Table 23. Date of International Manufacturers Enter into Glial Cell Line Derived Neurotrophic Factor Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Glial Cell Line Derived Neurotrophic Factor Sales by Type (2015-2020) (K Pcs)
Table 26. Global Glial Cell Line Derived Neurotrophic Factor Sales Share by Type (2015-2020)
Table 27. Global Glial Cell Line Derived Neurotrophic Factor Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Glial Cell Line Derived Neurotrophic Factor Revenue Share by Type (2015-2020)
Table 29. Glial Cell Line Derived Neurotrophic Factor Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Glial Cell Line Derived Neurotrophic Factor Sales by Application (2015-2020) (K Pcs)
Table 31. Global Glial Cell Line Derived Neurotrophic Factor Sales Share by Application (2015-2020)
Table 32. North America Glial Cell Line Derived Neurotrophic Factor Sales by Country (2015-2020) (K Pcs)
Table 33. North America Glial Cell Line Derived Neurotrophic Factor Sales Market Share by Country (2015-2020)
Table 34. North America Glial Cell Line Derived Neurotrophic Factor Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Glial Cell Line Derived Neurotrophic Factor Revenue Market Share by Country (2015-2020)
Table 36. North America Glial Cell Line Derived Neurotrophic Factor Sales by Type (2015-2020) (K Pcs)
Table 37. North America Glial Cell Line Derived Neurotrophic Factor Sales Market Share by Type (2015-2020)
Table 38. North America Glial Cell Line Derived Neurotrophic Factor Sales by Application (2015-2020) (K Pcs)
Table 39. North America Glial Cell Line Derived Neurotrophic Factor Sales Market Share by Application (2015-2020)
Table 40. Europe Glial Cell Line Derived Neurotrophic Factor Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Glial Cell Line Derived Neurotrophic Factor Sales Market Share by Country (2015-2020)
Table 42. Europe Glial Cell Line Derived Neurotrophic Factor Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Glial Cell Line Derived Neurotrophic Factor Revenue Market Share by Country (2015-2020)
Table 44. Europe Glial Cell Line Derived Neurotrophic Factor Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Glial Cell Line Derived Neurotrophic Factor Sales Market Share by Type (2015-2020)
Table 46. Europe Glial Cell Line Derived Neurotrophic Factor Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Glial Cell Line Derived Neurotrophic Factor Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Glial Cell Line Derived Neurotrophic Factor Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Glial Cell Line Derived Neurotrophic Factor Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Glial Cell Line Derived Neurotrophic Factor Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Glial Cell Line Derived Neurotrophic Factor Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Glial Cell Line Derived Neurotrophic Factor Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Glial Cell Line Derived Neurotrophic Factor Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Glial Cell Line Derived Neurotrophic Factor Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Glial Cell Line Derived Neurotrophic Factor Sales Market Share by Application (2015-2020)
Table 56. Latin America Glial Cell Line Derived Neurotrophic Factor Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Glial Cell Line Derived Neurotrophic Factor Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Glial Cell Line Derived Neurotrophic Factor Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Glial Cell Line Derived Neurotrophic Factor Revenue Market Share by Country (2015-2020)
Table 60. Latin America Glial Cell Line Derived Neurotrophic Factor Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Glial Cell Line Derived Neurotrophic Factor Sales Market Share by Type (2015-2020)
Table 62. Latin America Glial Cell Line Derived Neurotrophic Factor Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Glial Cell Line Derived Neurotrophic Factor Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Glial Cell Line Derived Neurotrophic Factor Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Glial Cell Line Derived Neurotrophic Factor Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Glial Cell Line Derived Neurotrophic Factor Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Glial Cell Line Derived Neurotrophic Factor Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Glial Cell Line Derived Neurotrophic Factor Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Glial Cell Line Derived Neurotrophic Factor Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Glial Cell Line Derived Neurotrophic Factor Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Glial Cell Line Derived Neurotrophic Factor Sales Market Share by Application (2015-2020)
Table 72. GlaxoSmithKline Plc Corporation Information
Table 73. GlaxoSmithKline Plc Description and Major Businesses
Table 74. GlaxoSmithKline Plc Glial Cell Line Derived Neurotrophic Factor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. GlaxoSmithKline Plc Product
Table 76. GlaxoSmithKline Plc Recent Development
Table 77. Treeway BV Corporation Information
Table 78. Treeway BV Description and Major Businesses
Table 79. Treeway BV Glial Cell Line Derived Neurotrophic Factor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Treeway BV Product
Table 81. Treeway BV Recent Development
Table 82. UniQure NV Corporation Information
Table 83. UniQure NV Description and Major Businesses
Table 84. UniQure NV Glial Cell Line Derived Neurotrophic Factor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. UniQure NV Product
Table 86. UniQure NV Recent Development
Table 87. Global Glial Cell Line Derived Neurotrophic Factor Sales Forecast by Regions (2021-2026) (K Pcs)
Table 88. Global Glial Cell Line Derived Neurotrophic Factor Sales Market Share Forecast by Regions (2021-2026)
Table 89. Global Glial Cell Line Derived Neurotrophic Factor Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 90. Global Glial Cell Line Derived Neurotrophic Factor Revenue Market Share Forecast by Regions (2021-2026)
Table 91. North America: Glial Cell Line Derived Neurotrophic Factor Sales Forecast by Country (2021-2026) (K Pcs)
Table 92. North America: Glial Cell Line Derived Neurotrophic Factor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 93. Europe: Glial Cell Line Derived Neurotrophic Factor Sales Forecast by Country (2021-2026) (K Pcs)
Table 94. Europe: Glial Cell Line Derived Neurotrophic Factor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 95. Asia Pacific: Glial Cell Line Derived Neurotrophic Factor Sales Forecast by Region (2021-2026) (K Pcs)
Table 96. Asia Pacific: Glial Cell Line Derived Neurotrophic Factor Revenue Forecast by Region (2021-2026) (US$ Million)
Table 97. Latin America: Glial Cell Line Derived Neurotrophic Factor Sales Forecast by Country (2021-2026) (K Pcs)
Table 98. Latin America: Glial Cell Line Derived Neurotrophic Factor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 99. Middle East and Africa: Glial Cell Line Derived Neurotrophic Factor Sales Forecast by Country (2021-2026) (K Pcs)
Table 100. Middle East and Africa: Glial Cell Line Derived Neurotrophic Factor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 101. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 102. Key Challenges
Table 103. Market Risks
Table 104. Main Points Interviewed from Key Glial Cell Line Derived Neurotrophic Factor Players
Table 105. Glial Cell Line Derived Neurotrophic Factor Customers List
Table 106. Glial Cell Line Derived Neurotrophic Factor Distributors List
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Glial Cell Line Derived Neurotrophic Factor Product Picture
Figure 2. Global Glial Cell Line Derived Neurotrophic Factor Sales Market Share by Type in 2020 & 2026
Figure 3. GSK-812 Product Picture
Figure 4. LAUR-301 Product Picture
Figure 5. TW-002 Product Picture
Figure 6. AMT-090 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Glial Cell Line Derived Neurotrophic Factor Sales Market Share by Application in 2020 & 2026
Figure 9. Amyotrophic Lateral Sclerosis
Figure 10. Brain Ischemia
Figure 11. Parkinson's Disease
Figure 12. Retinal Degeneration
Figure 13. Others
Figure 14. Glial Cell Line Derived Neurotrophic Factor Report Years Considered
Figure 15. Global Glial Cell Line Derived Neurotrophic Factor Market Size 2015-2026 (US$ Million)
Figure 16. Global Glial Cell Line Derived Neurotrophic Factor Sales 2015-2026 (K Pcs)
Figure 17. Global Glial Cell Line Derived Neurotrophic Factor Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Glial Cell Line Derived Neurotrophic Factor Sales Market Share by Region (2015-2020)
Figure 19. Global Glial Cell Line Derived Neurotrophic Factor Sales Market Share by Region in 2019
Figure 20. Global Glial Cell Line Derived Neurotrophic Factor Revenue Market Share by Region (2015-2020)
Figure 21. Global Glial Cell Line Derived Neurotrophic Factor Revenue Market Share by Region in 2019
Figure 22. Global Glial Cell Line Derived Neurotrophic Factor Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Glial Cell Line Derived Neurotrophic Factor Revenue in 2019
Figure 24. Glial Cell Line Derived Neurotrophic Factor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Glial Cell Line Derived Neurotrophic Factor Sales Market Share by Type (2015-2020)
Figure 26. Global Glial Cell Line Derived Neurotrophic Factor Sales Market Share by Type in 2019
Figure 27. Global Glial Cell Line Derived Neurotrophic Factor Revenue Market Share by Type (2015-2020)
Figure 28. Global Glial Cell Line Derived Neurotrophic Factor Revenue Market Share by Type in 2019
Figure 29. Global Glial Cell Line Derived Neurotrophic Factor Market Share by Price Range (2015-2020)
Figure 30. Global Glial Cell Line Derived Neurotrophic Factor Sales Market Share by Application (2015-2020)
Figure 31. Global Glial Cell Line Derived Neurotrophic Factor Sales Market Share by Application in 2019
Figure 32. Global Glial Cell Line Derived Neurotrophic Factor Revenue Market Share by Application (2015-2020)
Figure 33. Global Glial Cell Line Derived Neurotrophic Factor Revenue Market Share by Application in 2019
Figure 34. North America Glial Cell Line Derived Neurotrophic Factor Sales Growth Rate 2015-2020 (K Pcs)
Figure 35. North America Glial Cell Line Derived Neurotrophic Factor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America Glial Cell Line Derived Neurotrophic Factor Sales Market Share by Country in 2019
Figure 37. North America Glial Cell Line Derived Neurotrophic Factor Revenue Market Share by Country in 2019
Figure 38. U.S. Glial Cell Line Derived Neurotrophic Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. U.S. Glial Cell Line Derived Neurotrophic Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada Glial Cell Line Derived Neurotrophic Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 41. Canada Glial Cell Line Derived Neurotrophic Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America Glial Cell Line Derived Neurotrophic Factor Market Share by Type in 2019
Figure 43. North America Glial Cell Line Derived Neurotrophic Factor Market Share by Application in 2019
Figure 44. Europe Glial Cell Line Derived Neurotrophic Factor Sales Growth Rate 2015-2020 (K Pcs)
Figure 45. Europe Glial Cell Line Derived Neurotrophic Factor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Glial Cell Line Derived Neurotrophic Factor Sales Market Share by Country in 2019
Figure 47. Europe Glial Cell Line Derived Neurotrophic Factor Revenue Market Share by Country in 2019
Figure 48. Germany Glial Cell Line Derived Neurotrophic Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. Germany Glial Cell Line Derived Neurotrophic Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Glial Cell Line Derived Neurotrophic Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. France Glial Cell Line Derived Neurotrophic Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Glial Cell Line Derived Neurotrophic Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. U.K. Glial Cell Line Derived Neurotrophic Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Glial Cell Line Derived Neurotrophic Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Italy Glial Cell Line Derived Neurotrophic Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Glial Cell Line Derived Neurotrophic Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. Russia Glial Cell Line Derived Neurotrophic Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe Glial Cell Line Derived Neurotrophic Factor Market Share by Type in 2019
Figure 59. Europe Glial Cell Line Derived Neurotrophic Factor Market Share by Application in 2019
Figure 60. Asia Pacific Glial Cell Line Derived Neurotrophic Factor Sales Growth Rate 2015-2020 (K Pcs)
Figure 61. Asia Pacific Glial Cell Line Derived Neurotrophic Factor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Glial Cell Line Derived Neurotrophic Factor Sales Market Share by Region in 2019
Figure 63. Asia Pacific Glial Cell Line Derived Neurotrophic Factor Revenue Market Share by Region in 2019
Figure 64. China Glial Cell Line Derived Neurotrophic Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. China Glial Cell Line Derived Neurotrophic Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Glial Cell Line Derived Neurotrophic Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. Japan Glial Cell Line Derived Neurotrophic Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Glial Cell Line Derived Neurotrophic Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. South Korea Glial Cell Line Derived Neurotrophic Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Glial Cell Line Derived Neurotrophic Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. India Glial Cell Line Derived Neurotrophic Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Glial Cell Line Derived Neurotrophic Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Australia Glial Cell Line Derived Neurotrophic Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Glial Cell Line Derived Neurotrophic Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Taiwan Glial Cell Line Derived Neurotrophic Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Glial Cell Line Derived Neurotrophic Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Indonesia Glial Cell Line Derived Neurotrophic Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Glial Cell Line Derived Neurotrophic Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Thailand Glial Cell Line Derived Neurotrophic Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Glial Cell Line Derived Neurotrophic Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Malaysia Glial Cell Line Derived Neurotrophic Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Glial Cell Line Derived Neurotrophic Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Philippines Glial Cell Line Derived Neurotrophic Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Glial Cell Line Derived Neurotrophic Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 85. Vietnam Glial Cell Line Derived Neurotrophic Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific Glial Cell Line Derived Neurotrophic Factor Market Share by Type in 2019
Figure 87. Asia Pacific Glial Cell Line Derived Neurotrophic Factor Market Share by Application in 2019
Figure 88. Latin America Glial Cell Line Derived Neurotrophic Factor Sales Growth Rate 2015-2020 (K Pcs)
Figure 89. Latin America Glial Cell Line Derived Neurotrophic Factor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America Glial Cell Line Derived Neurotrophic Factor Sales Market Share by Country in 2019
Figure 91. Latin America Glial Cell Line Derived Neurotrophic Factor Revenue Market Share by Country in 2019
Figure 92. Mexico Glial Cell Line Derived Neurotrophic Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Mexico Glial Cell Line Derived Neurotrophic Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil Glial Cell Line Derived Neurotrophic Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Brazil Glial Cell Line Derived Neurotrophic Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina Glial Cell Line Derived Neurotrophic Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 97. Argentina Glial Cell Line Derived Neurotrophic Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Latin America Glial Cell Line Derived Neurotrophic Factor Market Share by Type in 2019
Figure 99. Latin America Glial Cell Line Derived Neurotrophic Factor Market Share by Application in 2019
Figure 100. Middle East and Africa Glial Cell Line Derived Neurotrophic Factor Sales Growth Rate 2015-2020 (K Pcs)
Figure 101. Middle East and Africa Glial Cell Line Derived Neurotrophic Factor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa Glial Cell Line Derived Neurotrophic Factor Sales Market Share by Country in 2019
Figure 103. Middle East and Africa Glial Cell Line Derived Neurotrophic Factor Revenue Market Share by Country in 2019
Figure 104. Turkey Glial Cell Line Derived Neurotrophic Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Turkey Glial Cell Line Derived Neurotrophic Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia Glial Cell Line Derived Neurotrophic Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. Saudi Arabia Glial Cell Line Derived Neurotrophic Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E Glial Cell Line Derived Neurotrophic Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 109. U.A.E Glial Cell Line Derived Neurotrophic Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Middle East and Africa Glial Cell Line Derived Neurotrophic Factor Market Share by Type in 2019
Figure 111. Middle East and Africa Glial Cell Line Derived Neurotrophic Factor Market Share by Application in 2019
Figure 112. North America Glial Cell Line Derived Neurotrophic Factor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. North America Glial Cell Line Derived Neurotrophic Factor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Europe Glial Cell Line Derived Neurotrophic Factor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Europe Glial Cell Line Derived Neurotrophic Factor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Asia Pacific Glial Cell Line Derived Neurotrophic Factor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Asia Pacific Glial Cell Line Derived Neurotrophic Factor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Latin America Glial Cell Line Derived Neurotrophic Factor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Latin America Glial Cell Line Derived Neurotrophic Factor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Middle East and Africa Glial Cell Line Derived Neurotrophic Factor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 121. Middle East and Africa Glial Cell Line Derived Neurotrophic Factor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Porter's Five Forces Analysis
Figure 123. Channels of Distribution
Figure 124. Distributors Profiles
Figure 125. Bottom-up and Top-down Approaches for This Report
Figure 126. Data Triangulation
Figure 127. Key Executives Interviewed
間質細胞由来因子1の世界市場（～2026年） Market Analysis and Insights: Global Stromal Cell Derived Factor 1 Market The global Stromal Cell Derived Factor 1 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Stromal Cell Derived Factor 1 Scope and Market Size Str…- 細胞株開発サービスの世界市場（～2026年） Market Analysis and Insights: Global Cell Line Development Services Market The global Cell Line Development Services market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Cell Line Development Services Scope and Market Size …
- 細胞株培養血清の世界市場（～2026年） Market Analysis and Insights: Global Cell Line Development Serum Market The global Cell Line Development Serum market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Cell Line Development Serum Scope and Market Size Cell Line…
- ヒト血漿由来治療薬の世界市場（～2026年） Market Analysis and Insights: Global Human Plasma-Derived Therapeutics Market The global Human Plasma-Derived Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Human Plasma-Derived Therapeutics Scope and Mar…
- 植物・植物由来薬剤の世界市場（～2026年） Botanical drugs are those drugs which are derived from medicinal plants. Plant derived drugs are combination of botanical as well as other approved drugs that contains plant materials, synthetic and semi synthetic substances. Botanical drugs consist of vegetable material, algae and macroscopic fungi…